Device Description: The Fisher Wallace Stimulator® is a wearable neurostimulation device that is regulated by the FDA for the treatment of depression, anxiety and insomnia.
Dosage: Once or twice a day for 20 minutes.
Mechanism of Action: Stimulation of serotonin production, alpha wave production and the default mode network; lowering of cortisol (stress hormone).
Patient Experience During Treatment: Comfortable, relaxed.
Side Effects: Less than 1% of patients may experience a temporary headache or dizziness.
Contraindications: Patients with implanted, electronic devices such as pacemakers should not use the Fisher Wallace Stimulator®.
Most Recent Published Clinical Trial: The treatment of bipolar II depression, conducted at Mount Sinai Beth Israel Hospital (2015).
Medicaid Approval Date: 2017 (MaineCare)
Private Insurance and Medicare Status: Out-of-pocket healthcare expense that is FSA and HSA eligible. TRICARE For Life and other plans with substantial medical device benefits will typically reimburse the purchase.
Return Policy: Patients may return their device for a refund within 30 days of receipt.